December 2013 FDA Recall Diclofenac Sodium And Misoprostol by Watson Laboratories, Inc.-(actavis) - Florida
D-1082-2014 - Failed Tablet/Capsule Specifications

This Class II drug recall was voluntarily initiated by Watson Laboratories, Inc.-(actavis) - Florida on December 20, 2013 for the product Diclofenac Sodium And Misoprostol. The FDA reported the reason for recall as failed tablet/capsule specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1082-2014

Reason for Recall
Failed Tablet/Capsule Specifications: Split tablets were found in the 12-month stability samples.
Initiated
12-20-2013
Reported
02-19-2014
Quantity
5987 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Watson Laboratories, Inc.-(Actavis) - Florida
Diclofenac Sodium and Misoprostol Delayed-Release Tablets, 75 mg/0.2 mg, 60-count bottle, Rx only, Manufactured by: Watson Laboratories, Inc., Corona, CA 92880, NDC 0591-0398-60, UPC 3 05910 39860 6.

Batch or Lot Expiration Information

Lot# 605957A, Exp 09/14